The global virus filtration market size is calculated at USD 5.22 billion in 2024, grew to USD 5.75 billion in 2025, and is projected to reach around USD 13.7 billion by 2034. The market is expanding at a CAGR of 10.5% between 2024 and 2034.
Top companies in the virus filtration are:
Rachel Dorin, co-founder and CEO of TeraPore Technologies, commented on the development of novel nanofiltration products, stating that their novel filter was designed to overcome manufacturing challenges and give their users robust and consistent performance. She also added that it is difficult to filter out viruses from new drugs due to their macro-molecular interactions, which can lead to filterability. The nanofiltration products were developed based on the company’s Intelligent Membrane platform that uses tunable self-assembled block co-polymers to reduce the risk of virus contamination in biological drugs.
If you have any questions, please feel free to contact us at sales@towardshealthcare.com